We found that blockade of IL-18 signaling in E7 DNA vaccine plus α-GalCer and MPL combination mice reduced E7-specific IFN-γ, and that this treatment decreased the protection against tumor growth compared with isotype control mAb. The gene discussed is IFNG; the disease is neoplasm.